These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3298136)

  • 41. Changes in granulocyte-monocyte colony-forming cells among leukocyte-interferon-treated chronic myelogenous leukemia patients.
    Talpaz M; Spitzer G; Hittelman W; Kantarjian H; Gutterman J
    Exp Hematol; 1986 Aug; 14(7):668-71. PubMed ID: 3460811
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interferon alpha induced and maintained complete remission in chronic granulocytic leukemia in relapse after bone marrow transplantation.
    Borgies P; Ferrant A; Delannoy A; Van den Berghe H; Michaux JL
    Bone Marrow Transplant; 1989 Jan; 4(1):127-8. PubMed ID: 2647178
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment with natural human interferon alpha of a CML-patient with antibodies to recombinant interferon alpha-2b.
    Freund M; von Wussow P; Knüver-Hopf J; Mohr H; Pohl U; Exeriede G; Link H; Wilke HJ; Poliwoda H
    Blut; 1988 Nov; 57(5):311-5. PubMed ID: 3196882
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Treatment of multiple myeloma with high-dose chemotherapy and transplantation of autologous hematopoietic stem cells and subsequent maintenance therapy with interferon alfa-2b or interferon alfa 2b and dexamethasone. Report of the ongoing study of the "4W" Czech Myeloma Group].
    Adam Z; Krejcí M; Bacovský J; Hejlová N; Kuca B; Svojgrová M; Franková H; Gumulec J; Janca J; Veprek K; Januska B; Lehanka F; Rezek Z; Praskac P; Cahová S; Vránová M; Papajík T; Králová E; Novotná J; Scudla V; Koza V; Drbal J; Faber E; Mareschová I; Hájek R
    Vnitr Lek; 1998 Jul; 44(7):400-8. PubMed ID: 9748876
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recombinant interferon alfa-2b in plaque-phase mycosis fungoides. Intralesional and low-dose intramuscular therapy.
    Vonderheid EC; Thompson R; Smiles KA; Lattanand A
    Arch Dermatol; 1987 Jun; 123(6):757-63. PubMed ID: 3579357
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term response of recurrent respiratory papillomatosis to treatment with lymphoblastoid interferon alfa-N1. Papilloma Study Group.
    Leventhal BG; Kashima HK; Mounts P; Thurmond L; Chapman S; Buckley S; Wold D
    N Engl J Med; 1991 Aug; 325(9):613-7. PubMed ID: 1861694
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Two busulfan-resistant cases of CML (chronic myelogenous leukemia) with good response to alpha-interferon treatment].
    Ogura H; Shirafuji N; Kumakawa T; Matsuda S; Horiuchi N; Kodo H; Fujii H; Asano S; Miwa S; Shinohara T
    Rinsho Ketsueki; 1987 Sep; 28(9):1599-604. PubMed ID: 3481405
    [No Abstract]   [Full Text] [Related]  

  • 48. Results of a phase II trial of oral bexarotene (Targretin) combined with interferon alfa-2b (Intron-A) for patients with cutaneous T-cell lymphoma.
    Straus DJ; Duvic M; Kuzel T; Horwitz S; Demierre MF; Myskowski P; Steckel S
    Cancer; 2007 May; 109(9):1799-803. PubMed ID: 17366595
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A review of the clinical studies of alpha-interferon in the management of multiple myeloma.
    Cooper MR
    Semin Oncol; 1991 Oct; 18(5 Suppl 7):18-29. PubMed ID: 1948125
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intralesional interferon alfa-2b for the treatment of genital warts.
    Welander CE; Homesley HD; Smiles KA; Peets EA
    Am J Obstet Gynecol; 1990 Feb; 162(2):348-54. PubMed ID: 2155531
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Short-term keloid treatment in vivo with human interferon alfa-2b results in a selective and persistent normalization of keloidal fibroblast collagen, glycosaminoglycan, and collagenase production in vitro.
    Berman B; Duncan MR
    J Am Acad Dermatol; 1989 Oct; 21(4 Pt 1):694-702. PubMed ID: 2553784
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interferon alfa-2c in chronic myelogenous leukemia (CML): hematologic, cytogenetic and molecular-genetic response of patients with chronic phase CML previously resistant to therapy with interferon gamma.
    Herrmann F; Jonas D; Helfrich SG; Lindemann A; Schleiermacher E; Mertelsmann R
    Blut; 1990 Oct; 61(4):226-31. PubMed ID: 2121299
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cost-benefit analysis of interferon alfa-2b in treatment of hairy cell leukemia.
    Ozer H; Golomb HM; Zimmerman H; Spiegel RJ
    J Natl Cancer Inst; 1989 Apr; 81(8):594-602. PubMed ID: 2495367
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of thrombocytosis in chronic myeloproliferative disorders with interferon alfa-2b.
    Seewann HL; Zikulnig R; Gallhofer G; Schmid C
    Eur J Cancer; 1991; 27 Suppl 4():S58-62; discussion S62-3. PubMed ID: 1799482
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recombinant interferon alfa-2b (Intron A) as post-induction therapy for responding multiple myeloma patients. M84 protocol.
    Mandelli F; Tribalto M; Avvisati G; Cantonetti M; Petrucci MT; Boccadoro M; Pileri A; Marmont F; Resegotti L; Lauta V
    Cancer Treat Rev; 1988 Jan; 15 Suppl A():43-8. PubMed ID: 3277709
    [No Abstract]   [Full Text] [Related]  

  • 56. [Interferon alfa-2B in chronic lymphatic leukemia of the B-cell type].
    Schlag R; Flieger D; Ziegler-Heitbrock HW; Hill W; Emmerich B; Thiel E
    Dtsch Med Wochenschr; 1990 Jul; 115(28-29):1088-95. PubMed ID: 2373039
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phase II trial of rDNA alfa 2b interferon in patients with malignant carcinoid tumor.
    Smith DB; Scarffe JH; Wagstaff J; Johnston RJ
    Cancer Treat Rep; 1987 Dec; 71(12):1265-6. PubMed ID: 3690534
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combination chemotherapy, glucocorticoids, and interferon alfa in the treatment of multiple myeloma: a Southwest Oncology Group study.
    Salmon SE; Crowley JJ; Grogan TM; Finley P; Pugh RP; Barlogie B
    J Clin Oncol; 1994 Nov; 12(11):2405-14. PubMed ID: 7964957
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biochemically targeted therapy of refractory leukemia and myeloid blast crisis of chronic granulocytic leukemia with Tiazofurin, a selective blocker of inosine 5'-phosphate dehydrogenase activity.
    Tricot G; Weber G
    Anticancer Res; 1996; 16(6A):3341-7. PubMed ID: 9042309
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A randomized clinical trial comparing melphalan/prednisone with or without interferon alfa-2b in newly diagnosed patients with multiple myeloma: a Cancer and Leukemia Group B study.
    Cooper MR; Dear K; McIntyre OR; Ozer H; Ellerton J; Canellos G; Bernhardt B; Duggan D; Faragher D; Schiffer C
    J Clin Oncol; 1993 Jan; 11(1):155-60. PubMed ID: 8418228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.